Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Clinical Trials
353 Articles Available
1
15
Can't find what you're looking for? Try our
advanced search
.
Endpoint
Array Biopharma Announces Braftovi + Mektovi + Cetuximab Meet Primary Endpoints in Metastatic Colorectal Cancer
PR-M05-19-NI-069
Phase I Study
Painting Tumors Is a Promising Approach to Improve Surgical Outcomes
PAO-M05-19-NI-024
Clinical Trial Data
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting
PR-M05-19-NI-060
Pfizer Announces Positive Top-Line Results from Phase 3 Study in Patients with Moderate to Severe Atopic Dermatitis
PR-M05-19-NI-055
Clinical Trials
Cerevance Achieves Key Endpoints in Phase 1 Clinical Trial of Novel Parkinson’s Disease Drug CVN424
PR-M05-19-NI-011
Trial Update
Merck Provides Update on Phase 3 KEYNOTE-062 Trial
PR-M04-19-NI-085
Clinical Supply Chain
The Patient-Centric Clinical Supply Chain for Cell and Gene Therapies
PAO-M04-19-CL-002
Phase I
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
PR-M04-19-NI-022
Partnership
Barc Lab and OWL Metabolomics Announce Strategic Partnership on Deploying Metabolomic Technology in Clinical Trials
PR-M04-19-NI-005
Clinical Study
Amygdala Neurosciences Announces Dosing the First Patients in the $12.4 Million NIH HEAL Initiative Funded SEARCH Program of Clinical Studies with ANS-6637
PR-M04-19-NI-006
Study Results
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness
PR-M03-19-NI-085
Bio-Analytical Assay
Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials
PR-M03-19-NI-079
Study Results
Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress
PR-M03-19-NI-078
Clinical Trials
Health Quest Sets out to Boost Participation in Clinical Trials with IBM Watson
PR-M03-19-NI-069
Announcement
Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
PR-M03-19-NI-062
Clinical Trials
Syntrix Announces First Patient Cohort Dosed in Phase 2 Study of Desmetramadol in Diabetic Neuropathic Pain
PR-M03-19-NI-058
Clinical Trials
Apple Watch to be Tested in Clinical Trial
PAO-M03-19-NI-026
FDA
FDA Announces Modernization Strategies for Clinical Trials of Precision Medicines
PAO-M03-19-NI-025
Enpoint
Lilly's CYRAMZA® Phase 3 RELAY Trial Met Primary Endpoint in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
PR-M03-19-NI-039
Clinical Results
Lipocine's LPCN 1144 for NASH Demonstrates Substantial Fatty Liver Resolution and Meaningful Liver Fat Reduction in NAFLD Population
PR-M03-19-NI-038
Pharmacokinetic Study
Galmed Reports Positive Results From Pharmacokinetic Split Dose Study of Aramchol
PR-M03-19-NI-037
Clinical Trials
Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
PR-M03-19-NI-035
Supply Chain Solutions
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma
PAP-Q1-2019-CL-008
Clinical Trials
Evolving Ethical Conduct Concerns in Clinical Trials
PAP-Q1-2019-NI-005
1
15
»
